Organicell Regenerative Medicine, Inc is a leading biotech company based in Fort Lauderdale, FL, specializing in the development of innovative biologic therapies and nano-technologies for a wide range of medical conditions. Their groundbreaking research in nanotechnology has led to the creation of a novel biologic candidate that represents the next frontier of regenerative medicine, with a focus on extracellular vesicle therapeutics. With a mission to pioneer the frontiers of medical science through rigorous research and innovation, Organicell is committed to creating life-changing and lifesaving therapies for important clinical conditions.
Organicell's flagship product, Zofin, has received FDA approval for Investigational New Drug (IND) applications in the treatment of knee osteoarthritis, chronic obstructive pulmonary disease (COPD), and COVID-19. Their unique approach involves creating ultra-high concentration biologics containing hundreds of billions of extracellular vesicles nanoparticles per ml, which contain over 300 bioactive agents that reduce inflammation and promote tissue regeneration. With multiple ongoing clinical trials and a patent-pending technology, Organicell is dedicated to developing FDA-approved treatments and revolutionizing the field of regenerative medicine.
Generated from the website